David W. Nikka

First Medical Group, Inc. owns and operates medical clinics in Eastern Europe and its medical centres provide healthcare services to expatriates and other local nationals. The company was founded in 1997 and is headquartered in Kapolei, HI.

Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA.

Lumisys, Inc. makes develops lighting solutions. The company makes products for integrated switching, retro-fit, demand response dimming, telephone override and many more. It was founded in 1985 and is located in Sunnyvale, CA.

Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP

Part of DVI, Inc., IPS Health Care, Inc. is a medical technical services concern. The company is based in Irvine, CA.

Dow Chemical Canada, Inc. manufactures chemicals and plastics products. It manufactures basic chemicals and plastics. The company's other products are ethylene glycol, polystyrene, and polyurethane resins. Dow Chemical Canada was founded in 1970 and is located in Calgary, Canada.

The Institute of Chartered Accountants in Ireland operates as an institute of chartered accountants. The non-profit company is based in Dublin, Ireland.

Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA.

Empirical Spine, Inc. develops minimally invasive, flexion-restricting stabilization devices for the spine. It offers LimiFlex Spinal Stabilization System which is a novel implant that provides segmental stability to the lumbar spine while still allowing motion and also used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis. The company was founded by Louis Fielding, John Colin Cahill, Ian Bennett and Todd F. Alamin in 2006 and is headquartered in San Carlos, CA.

Pacific Pharmaceutical Services LLC provides virtual pharmaceutical development and warehousing services. The company is based in Reno, NV.

FLG Partners LLC is a CFO solutions, CEO, and board advisory services provider based in Silicon Valley. The private company is based in Palo Alto, CA, and has subsidiaries in the United States. The company offers financial and operational leadership to a wide range of companies, from newly funded startups to Fortune 100 companies, across various sectors, including technology, life sciences, and consumer products. The firm's partners engage clients in interim or long-term assignments in leadership roles that typically are consulting engagements. FLG Partners has helped raise over $6 billion in growth financing, IPO, and M&A transactions for the firm's clients since January 2021. The company was founded by Douglas J. Lehrmann, Jeffrey S. Kuhn, Kyle W. Smith.

Part of Nevro Corp., Nevro Medical Ltd. develops and manufactures medical devices. The company is based in Cheltenham, UK and was founded in 2010.

Career Closet, Inc. provides vocational counseling services. The private company is based in Smyrna, GA.

Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022.

Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation.